HERM ROSENMAN

CIK 1230057 · Chief Financial Officer · last filed 2026-04-28

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$4.36M

Companies

7

Total Filings

105

Lifetime Open-Market Net

-$27.09M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NTRA Director 20,558 $212.07 $4.36M -$24.27M 47 2026-04-28
DermTech, Inc. (DMTK) Delisted Director 134,576 $0.09 $12.7K $274.6K 8 2023-06-05
Oxford Immunotec Global PLC (OXFD) Delisted Director 4,081 $0 7 2020-06-26
VIVUS INC (VVUS) Delisted Director 36,168 $159.0K 21 2020-02-24
GPRO Senior VP, Finance & CFO 0 $0.77 $0 -$3.25M 17 2012-08-02
ARYx Therapeutics, Inc. (ARYX) Delisted Director $0 3 2010-05-03
INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Director $0.04 $0 1 2007-09-14

Recent Filings · Page 11 of 11

105 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2007-11-28 GPRO Tax (F) −743 -$46.8K EDGAR
2007-11-09 ARYx Therapeutics, Inc. (ARYX) Delisted Grant (A) $0 EDGAR
2007-09-14 INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Grant (A) $0 EDGAR
2007-08-17 GPRO Mixed +6,257 -$45.3K EDGAR
2007-08-08 GPRO Mixed -$2.59M EDGAR
Showing 101105 of 105
Page 11 of 11
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.